Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 8,853,412

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,853,412
Title:Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
Abstract: The present invention relates to pyrrolidinone derivatives. The pyrrolidinone derivatives are GPR119 modulators and useful for the prevention and/or treatment of diabetes, obesity, dyslipidemia and related disorders. The invention furthermore relates to the use of pyrrolidinone derivatives as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.
Inventor(s): Schwink; Lothar (Frankfurt am Main, DE), Bossart; Martin (Frankfurt am Main, DE), Glombik; Heiner (Frankfurt am Main, DE), Gossel; Matthias (Frankfurt am Main, DE), Kadereit; Dieter (Frankfurt am Main, DE), Klabunde; Thomas (Frankfurt am Main, DE), Maier; Thomas (Frankfurt am Main, DE), Stengelin; Siegfried (Frankfurt am Main, DE)
Assignee: Sanofi (Paris, FR)
Application Number:14/048,425
Patent Claims:see list of patent claims

Details for Patent 8,853,412

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Aegerion MYALEPT metreleptin INJECTABLE;INJECTION 125390 001 2014-02-24 ➤ Sign Up Sanofi (Paris, FR) 2032-10-09 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.